Related Experiment Video

Updated: Aug 2, 2026

Strategies for Tracking Anastasis, A Cell Survival Phenomenon that Reverses Apoptosis
12:55

Strategies for Tracking Anastasis, A Cell Survival Phenomenon that Reverses Apoptosis

Published on: February 16, 2015

The dilemma of the strive for apoptosis in oncology: mind the heart

Patrick J Perik1, Elisabeth G E de Vries, Jourik A Gietema

  • 1Department of Cardiology, Thorax center, University Hospital Groningen, Groningen, 9700 RB, The Netherlands.

Critical Reviews in Oncology/Hematology
|January 22, 2005
PubMed

Insights

This review explores cardiomyocyte apoptosis, crucial for both cancer treatment and heart failure. Understanding these pathways aids in developing safer anticancer drugs and novel heart failure therapies.

Area of Science:

  • Cardiology
  • Oncology
  • Molecular Biology

Background:

  • Apoptosis (programmed cell death) is a key target in cancer therapy, with drugs designed to induce it in malignant cells.
  • However, non-selective anticancer drugs can induce apoptosis in healthy tissues, notably the myocardium, leading to cardiotoxicity.
  • Conversely, apoptosis contributes to heart failure pathogenesis, making its inhibition a therapeutic goal for cardiologists.

Purpose of the Study:

  • To review recent advancements in understanding the mechanisms of cardiomyocyte apoptosis.
  • To discuss the dual role of apoptosis in cancer and heart disease, highlighting the divergent therapeutic strategies.

Main Methods:

  • Literature review of current research on apoptotic pathways.
  • Analysis of mitochondrial and death receptor-mediated apoptosis.
  • Exploration of apoptosis induced by growth factor receptor signaling inhibition.

Main Results:

  • Detailed insights into the molecular mechanisms driving cardiomyocyte apoptosis.
  • Identification of common and distinct apoptotic pathways relevant to oncology and cardiology.
  • Understanding of how growth factor signaling impacts cardiomyocyte survival.

Conclusions:

  • Elucidating cardiomyocyte apoptosis mechanisms is vital for improving anticancer drug safety.
  • This knowledge can drive the development of targeted therapies for heart failure.
  • A deeper understanding facilitates a more integrated approach to treating cancer patients with cardiac comorbidities.

More Related Videos

Detecting Anastasis In Vivo by CaspaseTracker Biosensor20:16

Detecting Anastasis In Vivo by CaspaseTracker Biosensor

Published on: February 1, 2018

Flow Cytometric Detection of Newly-formed Breast Cancer Stem Cell-like Cells After Apoptosis Reversal11:21

Flow Cytometric Detection of Newly-formed Breast Cancer Stem Cell-like Cells After Apoptosis Reversal

Published on: January 26, 2019

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Ethical Dilemmas II01:30

Ethical Dilemmas II

Resolving an ethical dilemma in healthcare involves a systematic approach that considers every aspect of the issue, respecting both the patient's needs and values and the healthcare professional's ethical obligations. Here are potential steps to resolve an ethical dilemma: